MA54889B1 - USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASIA - Google Patents

USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASIA

Info

Publication number
MA54889B1
MA54889B1 MA54889A MA54889A MA54889B1 MA 54889 B1 MA54889 B1 MA 54889B1 MA 54889 A MA54889 A MA 54889A MA 54889 A MA54889 A MA 54889A MA 54889 B1 MA54889 B1 MA 54889B1
Authority
MA
Morocco
Prior art keywords
myeloproliferative
telomerase inhibitors
treatment
myeloproliferative disorders
neoplasia
Prior art date
Application number
MA54889A
Other languages
French (fr)
Other versions
MA54889A1 (en
Inventor
Monic Stuart
Stephen Kelsey
Original Assignee
Geron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/841,711 external-priority patent/US9375485B2/en
Application filed by Geron Corp filed Critical Geron Corp
Priority claimed from PCT/US2013/070437 external-priority patent/WO2014088785A1/en
Publication of MA54889A1 publication Critical patent/MA54889A1/en
Publication of MA54889B1 publication Critical patent/MA54889B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des procédés pour réduire la prolifération de cellules progénitrices néoplasiques et soulager des symptômes associés chez des individus diagnostiqués avec ou suspectés d'avoir des troubles myéloprolifératifs, tels que la thrombocytémie essentielle (te). La présente invention concerne en outre des procédés d'utilisation d'inhibiteurs de télomérase pour maintenir les numérations plaquettaires sanguines dans des plages relativement normales dans le sang d'individus diagnostiqués avec ou suspectés d'avoir des troubles myéloprolifératifs, tels que te.The present invention relates to methods for reducing the proliferation of neoplastic progenitor cells and alleviating associated symptoms in individuals diagnosed with or suspected of having myeloproliferative disorders, such as essential thrombocythemia (e). The present invention further relates to methods of using telomerase inhibitors to maintain blood platelet counts within relatively normal ranges in the blood of individuals diagnosed with or suspected of having myeloproliferative disorders, such as te.

MA54889A 2013-03-15 2013-11-15 USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASIA MA54889B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/841,711 US9375485B2 (en) 2012-12-07 2013-03-15 Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
PCT/US2013/070437 WO2014088785A1 (en) 2012-12-07 2013-11-15 Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
US201513841711A 2015-03-15 2015-03-15

Publications (2)

Publication Number Publication Date
MA54889A1 MA54889A1 (en) 2022-10-31
MA54889B1 true MA54889B1 (en) 2023-07-31

Family

ID=83995786

Family Applications (1)

Application Number Title Priority Date Filing Date
MA54889A MA54889B1 (en) 2013-03-15 2013-11-15 USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASIA

Country Status (1)

Country Link
MA (1) MA54889B1 (en)

Also Published As

Publication number Publication date
MA54889A1 (en) 2022-10-31

Similar Documents

Publication Publication Date Title
MA45504A1 (en) Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasias
MA35365B1 (en) Ringed Pyrimidines substituted and their use
MA34248B1 (en) SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND THEIR USE
MA35844B1 (en) Pyrimidines and substituted ringed triazines and their use
MA38060A1 (en) Amidazo [1,2-a] amino-substituted pyridincarboxamides and their use
MA39211B1 (en) Tricyclic compounds as anti-cancer agents
WO2014153115A3 (en) Compositions and methods for reprogramming hematopoietic stem cell lineages
MA38365A1 (en) Ringed pyrimidines with trifluoromethyl substitution and corresponding use
PH12015500114A1 (en) HUMAN ANTIBODIES TO GFRa3 AND METHODS OF USE THEREOF
EP2539351A4 (en) Fluid for accommodating intraocular lenses
EA201400119A1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND THEIR APPLICATION
GB0711327D0 (en) Diagnostic method
MA38925B1 (en) Substituted phenylalanine derivatives
MX2014010940A (en) The use of antithrombin in the treatment of pre-eclampsia.
MX2015010023A (en) Anti-cd83 antibodies and use thereof.
NZ631639A (en) Methods and compositions for treating and diagnosing acute myocardial infarction
MA54889B1 (en) USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASIA
WO2015134631A8 (en) Compositions and methods for identifying b cell malignancies responsive to b cell depleting therapy
EA201491522A1 (en) METHODS OF TREATING DISORDERS OF GAIT AND / OR BALANCE IN PATIENTS WITH MULTIPLE SCLEROSIS USING AMINOPYRIDINE
MX2015012381A (en) Fungal immunogens and related materials and methods.
TR201818988T4 (en) Methods for alleviating the symptoms of multiple sclerosis based on compositions containing apoaequorin.
EA201990799A1 (en) USE OF TELOMERASE INHIBITORS FOR TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
FR3011468B1 (en) USE OF ODIPARCIL IN THE TREATMENT OF MUCOPOLYSACCHARIDOSE
朱琳 Expression of Sema4D in patients with cerebral infarction and its clinical significance
MA35029B1 (en) TREATMENT OF HEPATITIS C VIRUS INFECTION WITH ALISPORIVIR